色偷偷av男人的天堂,亚洲 欧美 激情 小说 另类,激情综合五月,国产精品亚洲成在人线

Biologic Product Deviation Monitors

DIVISION 2: Thanh B. Tran, LOS-DO (949) 608-3504

Bioresearch Monitors

BIMO EAST: Sheri Oliver (240) 402-1018

BIMO WEST: Hector Colon (301) 796-3389

Blood Bank Monitors

DIVISION 1: Cassandra Winters CIN-DO (513) 246-4134 x1121

DIVISION 2: Aneel Sandhu SAN-DO (510) 337-6875

Blood Registration Monitors

DIVISION 1: Cassandra Winters CIN-DO (513) 246-4134 x1121

DIVISION 2: Aneel Sandhu SAN-DO (510) 337-6875

Complaint Coordinators

UNDER PROGRAM OFFICES

Criminal Investigations Monitors

ATL-DO: Dawne Hines (404) 253-2242

BLT-DO: Constance Richard-Math (410) 779-5430

CHI-DO: Vacant

CIN-DO: David Miser (513) 679-2700 x2120

DAL-DO: Karen Daugherty 214-253-5228

DEN-DO: CAPT. Thomas R. Berry (303) 236-3028

DET-DO: Keith J. Jasukaitis (313) 393-8141

FLA-DO: Kathleen Sinninger (407) 475-4715

KAN-DO: Gerald D. Bromley, (913) 495-5120

LOS-DO: Monica Maxwell (949) 608-4454

MIN-DO: Greg Smith (612) 758-7179

NOL-DO: Thomas D. Clarida (615) 366-7827

NWE-DO: Lori Holmquist (781) 587-7437

NWJ-DO: Nancy Rolli (973) 331-4902

PHI-DO: Karyn M. Campbell (215) 717-3731

SAN-DO: Lawton Lum (510) 337-6792

SEA-DO: Celeste M. Corcoran (425) 483-4971

SJN-DO: Maridalia Torres (787) 729-8721

SWID: Vacant (956) 726-2972 x101

Device Profile and Program Monitors

Division 1: Lisa Leveille, NWE-DO, (781) 587-7485

Division 2: Trang Cox, ATL-DO, (404) 669-4540

Division 3: Bryan Love, DEN-DO, (303) 236-3059

Device Registration Monitors

Division 1: Daniel Tammariello, PHI-DO, (412) 644-3394 x 16

Division 2: Mary Kay Concannon, KAN-DO, (314) 64501167 x 124

Division 3: Eric Anderson, SAN-DO, (510) 337-6752

Drug Defect Reporting Monitors

DIVISION 1

Toyin Oladimeji, Drug Defect Reporting Monitors, BLT-DO, (410) 779-5115

Margaret Sands, Drug Defect Reporting Monitors, NWE-DO, (781) 587-7483

Melissa Roy, Drug Defect Reporting Monitors, NWJ-DO, (973) 331-4924 x4924

Nancy Scheraga, Drug Defect Reporting Monitors, NWJ-DO, (973) 331-4910

Mathew Spataro, Drug Defect Reporting Monitors, NYK-DO, (914) 468-6166 x17

Gayle Lawson, Drug Defect Reporting Monitors, PHI-DO, (215) 717-3737

DIVISION 2

Bonita Chester, Drug Defect Reporting Monitors, ATL-DO, (864) 234-9966

Charles Brown, Drug Defect Reporting Monitors, DAL-DO, (214) 253-5245

Jose Martinez, Drug Defect Reporting Monitors, DAL-DO, (210) 308-1402

Joanne King, Drug Defect Reporting Monitors, FLA-DO, (305) 816-1418

June Page, Drug Defect Reporting Monitors, NOL-DO, (615) 366-7835

Frances DeJesus, Drug Defect Reporting Monitors, SJN-DO, (787) 729-8543

DIVSION 3

Patrick Cummings, Drug Defect Reporting Monitors, CHI-DO, (612) 758-7193

Dionne Pass, Drug Defect Reporting Monitors, CIN-DO, (513) 679-2700 x2170

Emily Orban, Drug Defect Reporting Monitors, DET-DO, (313) 393-8177

Carl Huffman, Drug Defect Reporting Monitors, KAN-DO, (913) 495-5190

DIVISION 4

Nayan Patel, Drug Defect Reporting Monitors, DEN-DO, (303) 236-9650

Richmond Yip, Drug Defect Reporting Monitors, LOS-DO, (949) 608-3556

Lucila Nwatu, Drug Defect Reporting Monitors, SAN-DO, (510) 337-6801

Richmond Yip, Drug Defect Reporting Monitors, SEA-DO, (949) 608-3556

Drug Efficacy Study Implementation (DESI) Monitors

DIVISION 1

Djamila Harouaka, Drug Efficacy Study Implementation Monitors, BLT-DO, (240) 402-0224

Margaret Sands, Drug Efficacy Study Implementation Monitors, NWE-DO, (781) 587-7483

Meyer Slobotsky, Drug Efficacy Study Implementation Monitors, NWJ-DO, (732) 390-3806

Matthew Spataro, Drug Efficacy Study Implementation Monitors, NYK-DO, (914) 468-6166 x17

Karyn Campbell, Drug Efficacy Study Implementation Monitors, PHI-DO, (215) 717-3731

DIVISION 2

Seneca Toms, Drug Efficacy Study Implementation Monitors, ATL-DO, (919) 420-1117

Charles Brown, Drug Efficacy Study Implementation Monitors, DAL-DO, (214) 253-5245

Jose Martinez, Drug Efficacy Study Implementation Monitors, DAL-DO, (210) 308-1402

Karlton Watson, Drug Efficacy Study Implementation Monitors, DAL-DO, (214) 253-5228

Joanne King, Drug Efficacy Study Implementation Monitors, FLA-DO, (305) 816-1418

Carl Huffman, Drug Efficacy Study Implementation Monitors, KAN-DO, (913) 495-5190

Cynthia Gibson, Drug Efficacy Study Implementation Monitors, NOL-DO, (251) 344-8208 x105

Frances De Jesus, Drug Efficacy Study Implementation Monitors, SJN-DO, (787) 729-8543

DIVISION 3

Patrick Cummings, Drug Efficacy Study Implementation Monitors, CHI-DO, (612) 758-7194

Steven Eastham, Drug Efficacy Study Implementation Monitors, CIN-DO, (513) 246-4134 x1103

Jeffrey Meng, Drug Efficacy Study Implementation Monitors, DET-DO, (313) 393-8272

Patrick Cummings, Drug Efficacy Study Implementation Monitors, MIN-DO, (612) 758-7200

DIVISION 4

Zachery Miller, Drug Efficacy Study Implementation Monitors, DEN-DO, (303) 236-3097

Richmond Yip, Drug Efficacy Study Implementation Monitors, LOS-DO, (949) 608-3556

Lucila Nwatu, Drug Efficacy Study Implementation Monitors, SAN-DO, (510) 337-6801

Richmond Yip, Drug Efficacy Study Implementation Monitors, SEA-DO, (949) 608-3556

Drug Field Alert Monitors

DIVISION 1

Ernie Bizjak, Drug Field Alert Monitors, BLT-DO, (410) 779-5715

Margaret Sands, Drug Field Alert Monitors, NWE-DO, (781) 587-7483

Maria Estrella, Drug Field Alert Monitors, NWJ-DO, (732) 390-3820

Matthew Spataro, Drug Field Alert Monitors, NYK-DO, (914) 468-6166 x17

Gayle Lawson, Drug Field Alert Monitors, PHI-DO, (215) 717-3731

DIVISION 2

Tamara Henderson, Drug Field Alert Monitors, ATL-DO, (404) 669-4549 x4549

Charles Brown, Drug Field Alert Monitors, DAL-DO, (214) 253-5245

Jose Martinez, Drug Field Alert Monitors, DAL-DO, (210) 308-1402

Karlton Watson, Drug Field Alert Monitors, DAL-DO, (214) 253-5228

Margaret Annes, Drug Field Alert Monitors, DAL-DO, (405) 609-8742 x1

Stephen Brown, Drug Field Alert Monitors, DAL-DO, (713) 293-1414

Jennifer Lalama, Drug Field Alert Monitors, FLA-DO, (305) 816-1419

Joanne King, Drug Field Alert Monitors, FLA-DO, (305) 816-1418

Claire Minden, Drug Field Alert Monitors, NOL-DO, (985) 249-7936 x 1104

Edwin Ramos, Drug Field Alert Monitors, SJN-DO, (787) 729-8662

Johnetta Walters, Drug Field Alert Monitors (backup), ATL-DO, (404)253-1176

Larry Hampton, Drug Field Alert Monitors (backup), ATL-DO, (404) 669-4442

Sonya Edmonds, Drug Field Alert Monitors (backup), ATL-DO, (919) 420-1121

Brandon Heitmeier, Drug Field Alert Monitors (backup), NOL-DO, (423) 855-6630

DIVSION 3

Patrick Cummings, Drug Field Alert Monitors, CHI-DO, (612) 758-7195

Steven Eastham, Drug Field Alert Monitors, CIN-DO, (513) 246-4134 x1104

Emily Orban, Drug Field Alert Monitors, DET-DO, (313) 393-8177

Jeffrey Meng, Drug Field Alert Monitors, DET-DO, (313) 393-8272

Carl Huffman, Drug Field Alert Monitors, KAN-DO, (913) 495-5190

DIVISION 4

Nalini Lebzelter, Drug Field Alert Monitors, DEN-DO, (303) 236-3008

Zachery Bogorad, Drug Field Alert Monitors, DEN-DO, (303) 236-9725

Katherine Jacobitz, Drug Field Alert Monitors, LOS-DO, (619) 941-3777

Lucila Nwatu, Drug Field Alert Monitors, SAN-DO, (510) 337-6801

Zachary Bogorad, Drug Field Alert Monitors, SEA-DO, (303-236-9725) 910-9659

Drug Listing Monitors

DIVISION 1

Jonathan Chapman, Drug Listing Monitors, BLT-DO, (703) 538-2176 x104

Margaret Sands, Drug Listing Monitors, NWE-DO, (781) 587-7483

Meyer Slobotsky, Drug Listing Monitors, NWJ-DO, (732) 390-3806

Matthew Spataro, Drug Listing Monitors, NYK-DO, (914) 468-6166 x17

John Mastalski, Drug Listing Monitors, PHI-DO, (302) 573-6447 x102

DIVISION 2

Susan Oladeji, Drug Listing Monitors, ATL-DO, (404) 669-4547

Charles Brown, Drug Listing Monitors, DAL-DO, (214) 253-5245

Jose Martinez, Drug Listing Monitors, DAL-DO, (210) 308-1402

Karlton Watson, Drug Listing Monitors, DAL-DO, (214) 253-5228

Angela Glenn, Drug Listing Monitors, FLA-DO, (407) 475-4751

Cynthia Gibson, Drug Listing Monitors, NOL-DO, (251) 344-8208 x105

Frances De Jesus, Drug Listing Monitors, SJN-DO, (787) 729-8543

DIVSION 3

Patrick Cummings, Drug Listing Monitors, CHI-DO, (612) 758-7196

Steven Eastham, Drug Listing Monitors, CIN-DO, (513) 246-4134 x1105

Emily Orban, Drug Listing Monitors, DET-DO, (313) 393-8177

Michele L Obert, Drug Listing Monitors, KAN-DO, (913) 495-5146

Patrick Cummings, Drug Listing Monitors, MIN-DO, (612) 758-7202

DIVISION 4

Tenzin Jangchup, Drug Listing Monitors, DEN-DO, (303) 236-9651

Lynette Terry, Drug Listing Monitors, LOS-DO, (949) 608-3495

Rumany Penn, Drug Listing Monitors, SAN-DO, (650) 244-4726

Lynette Terry, Drug Listing Monitors, SEA-DO, (949) 608-3495

Drug Monitors

DIVISION 1

Vacant, Drug Monitors, BLT-DO,

Margaret Sands, Drug Monitors, NWE-DO, (781) 587-7483

Meyer Slobotsky, Drug Monitors, NWJ-DO, (732) 390-3806

Matthew Spataro, Drug Monitors, NYK-DO, (914) 468-6166 x17

Karyn Campbell, Drug Monitors, PHI-DO, (215) 717-3731

DIVISION 2

LaReese Thomas, Drug Monitors, ATL-DO, (404) 253-1245

Charles Brown, Drug Monitors, DAL-DO, (214) 253-5245

Jose Martinez, Drug Monitors, DAL-DO, (210) 308-1402

Karlton Watson, Drug Monitors, DAL-DO, (214) 253-5228

Joanne King, Drug Monitors, FLA-DO, (305) 816-1418

Carl Huffman, Drug Monitors, KAN-DO, (913) 495-5190

Cynthia Gibson, Drug Monitors, NOL-DO, (251) 344-8208 x105

Frances De Jesus, Drug Monitors, SJN-DO, (787) 729-8543

DIVISION 3

Patrick Cummings, Drug Monitors, CHI-DO, (612) 758-7197

Steven Eastham, Drug Monitors, CIN-DO, (513) 246-4134 x1106

Jeffrey Meng, Drug Monitors, DET-DO, (313) 393-8272

Patrick Cummings, Drug Monitors, MIN-DO, (612) 758-7203

DIVISION 4

Nalini Lebzelter, Drug Monitors, DEN-DO, (303) 236-3008

Richmond Yip, Drug Monitors, LOS-DO, (949) 608-3556

Lucila Nwatu, Drug Monitors, SAN-DO, (510) 337-6801

Richmond Yip, Drug Monitors, SEA-DO, (949) 608-3556

Drug Pre-Approval Monitors

DIVISION 1

Ernie Bizjak, Drug Pre-Approval Monitors, BLT-DO, (410) 779-5715

Steven Donald, Drug Pre-Approval Monitors, BLT-DO, (410) 779-5444

Toyin Oladimeji, Drug Pre-Approval Monitors, BLT-DO, (410) 779-5116

Margaret Sands, Drug Pre-Approval Monitors, NWE-DO, (781) 587-7483

Maya Davis, Drug Pre-Approval Monitors, NWE-DO, (860) 240-4289 x25

Doug Kovacs, Drug Pre-Approval Monitors, NWJ-DO, (973) 331-4936

Maria Estrella, Drug Pre-Approval Monitors, NWJ-DO, (732) 390-3820

Alice Tsao, Drug Pre-Approval Monitors, NYK-DO, (718) 662-5657

Matthew Spataro, Drug Pre-Approval Monitors, NYK-DO, (914) 468-6166 x17

Gayle Lawson, Drug Pre-Approval Monitors, PHI-DO, (215) 717-3737

Karyn Campbell, Drug Pre-Approval Monitors, PHI-DO, (215) 717-3731

DIVISION 2

Johnetta Walters, Drug Pre-Approval Monitors, ATL-DO, (404)253-1176

LaReese Thomas, Drug Pre-Approval Monitors, ATL-DO, (404) 253-1245

Charles Brown, Drug Pre-Approval Monitors, DAL-DO, (214) 253-5245

Jose Martinez, Drug Pre-Approval Monitors, DAL-DO, (210) 308-1402

Karlton Watson, Drug Pre-Approval Monitors, DAL-DO, (214) 253-5228

Jennifer Lalama, Drug Pre-Approval Monitors, FLA-DO, (305) 816-1419

Brandon Heitmeier, Drug Pre-Approval Monitors, NOL-DO, (423) 855-6630

Cynthia Gibson, Drug Pre-Approval Monitors, NOL-DO, (251) 344-8208 x105

Frances De Jesus, Drug Pre-Approval Monitors, SJN-DO, (787) 729-8543

DIVISION 3

Patrick Cummings, Drug Pre-Approval Monitors, CHI-DO, (612) 758-7198

Lindsay Schwierjohann, Drug Pre-Approval Monitors, CIN-DO, (513) 246-4134

Nicholas Paulin, Drug Pre-Approval Monitors, CIN-DO, (513) 246-4134 x1109

Steven Eastham, Drug Pre-Approval Monitors, CIN-DO, (513) 246-4134 x1107

Emily Orban, Drug Pre-Approval Monitors, DET-DO, (313) 393-8177

Robert Barbosa, Drug Pre-Approval Monitors, DET-DO, (317) 226-6500 x 122

Michele L Obert, Drug Pre-Approval Monitors, KAN-DO, (913) 495-5146

Robert Ham, Drug Pre-Approval Monitors, KAN-DO, 314-645-1167 x150

DIVISION 4

Nalini Lebzelter, Drug Pre-Approval Monitors, DEN-DO, (303) 236-3008

Nayan Patel, Drug Pre-Approval Monitors, DEN-DO, (303) 236-3010

Katherine Jacobitz, Drug Pre-Approval Monitors, LOS-DO, (619) 941-3777

Richmond Yip, Drug Pre-Approval Monitors, LOS-DO, (949) 608-3556

Ashar Parikh, Drug Pre-Approval Monitors, SAN-DO, (916) 930-3674 x1102

Lucila Nwatu, Drug Pre-Approval Monitors, SAN-DO, (510) 337-6801

Anita Narula, Drug Pre-Approval Monitors, SEA-DO, (425) 302-0466

Zachery Miller, Drug Pre-Approval Monitors (Primary), DEN-DO, (303) 236-3097